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ABSTRACT 
Biofilms are microbial communities that cause serious chronic infections in the environment by enhancing antimicrobial resist ance. 
Bacteria in the biofilm can be up to a thousand times more resistant to antibiotics than the same bacteria circulating in a p lanktonic state. 
The emergence of antibiotic-resistant microorganism has led to the exploration of different therapeutic agents like ribosomally 
synthesized microorganism peptides referred to as bacteriocins. In this study, bacteriocin producing bacteria Pseudomonas aeruginosa  
isolated from a soil sample. It was found to be effective against Methicillin-resistant Staphylococcus aureus (MRSA). Furthermore the 
bacteriocin was partial purified by ammonium sulfate, the precipitate has highly effective against M RSA (400AU/mL). MRSA cells were 
treated with precipitated culture supernatant of P. aeruginosa TA6 was analyzed by FT-IR. The treated and untreated MRSA showed band 
variations at 682.59 and 3442.15cm-1 corresponding to the alkyl and amide group respectively. Bacteriocin showed marked inhibition 
activity against the biofilm of MRSA. About 0.05% and 0.02% attachment of biofilm was observed in the presence of 1X MIC (10 μg/mL) 
and 2X MIC (20 g/mL) respectively. Our results recommend that bacteriocins that make stable pores on biofilm cells are extremely potent 
for the treatment of MRSA biofilm infections. 
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INTRODUCTION 
Biofilms are often associated with chronic disease states that 
create long-term problems for environment. Biofilms have 
been known to throw into physical and chemical protection 
as well as defense from antimicrobials1. In clinical settings, 
the continued existence of biofilms on medical devices and 
hospital equipment permits certain pathogens to easily 
transmit a disease to patients. Once infected, pathogen-
associated biofilms can avoid human host immune defenses 
and are frequently associated with persistent infections, 
often resistant to antibiotic therapy2. Away from 
antimicrobial resistance, bacteria present in a biofilm are 
also defiant to various physicochemical stresses, enabling 
biofilms to persist in even the harshest of conditions. In the 
food industry, biofilms can cause food-borne disease 
outbreaks. Furthermore, inefficient cleaning commands may 
be a causative factor in the spread of resistance in hospital 
environments3.  
A recent comprehensive review described the efficacy of 
antibiotics in combination with other antimicrobial peptides 
and essential oils, as well as the effectiveness of biofilm-
degrading enzymes, quorum sensing inhibitors and 
nanoparticles as potential antibiofilm agents4. Due to the 
extensive resistance of biofilms to conventional antibiotics, 
one alternative avenue to embark upon this problem is to 
harness bacteriocins as antimicrobials either independently 
or in combination with existing proven antimicrobials, to 
target biofilms. The major differentiation between 
bacteriocins and antibiotics is that bacteriocins restrict their 
activity to strains of species associated with the producing 
species and particularly to strains of the same species. 
Besides, bacteriocins are ribosomally synthesized and 
produced throughout the primary phase of growth, though 
antibiotics are usually secondary metabolites5. Bacteriocins 
usually have a low molecular weight (rarely over 10 kDa) 
they undergo posttranslational modification and can be 
easily degraded by proteolytic enzymes especially by the 
proteases of the mammalian gastrointestinal tract, which 
makes them secure for human consumption. 
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Bacteriocins are in general cationic, amphipathic molecules 
as they contain an excess of lysyl and arginyl residues6, 7. 
There are some reports available on bacteriocin-producing 
Pseudomonas aeruginosa isolated from soil samples but 
limited studies describe soil isolates8, 9. P. aeruginosa can 
compete, is by producing chromosomally encoded 
bacteriocins, called pyocins. Pyocins are ribosomally 
synthesized bacteriocins which are produced to kill 
competitors of the same species10. The pyocins produced by 
P. aeruginosa are classified into three major types: S, R- and 
F-pyocins11. R- and F-type pyocins are produced by more 
than 90% of P. aeruginosa strains, while 70% of P. 
aeruginosa strains can produce at least one S-type pyocin. 
The present study was partially purified bacteriocin 
extracted from P. aeruginosa TA6 culture showed biofilm 
activity against Methicillin‐resistant Staphylococcus aureus 
(MRSA). 
MATERIALS AND METHODS 
Preparation and partial purification of Bacteriocin 
The bacteriocin producing bacteria P. aeruginosa TA6 was 
grown in Luria broth and it was incubated at 37 °C for 18 
hours. The following time, the culture broth was subjected to 
centrifugation at 10,000 rpm for 15 min at 4 °C for 
separation of bacterial cells. The supernatant was filter-
sterilized by passing through a 0.45 µm pore sized filter 
membrane (Millipore, MA, USA). This CFS was further 
partially purified by ammonium sulfate precipitation12. To 
achieve the maximum saturation of bacteriocin, 70% of 
ammonium sulfate was added by constant agitation at 4 °C at 
overnight. Then precipitates were recovered by 
centrifugation at 10,000 rpm for 30 min at 4 °C. The 
resulting pellets were re-suspended in 20 mM sodium 
phosphate buffer (pH 7.2) and were designated as `partially 
purified bacteriocin’13.  For removal of the salt from the 
partially purified bacteriocin, ultra-filtration was done 
through a pre-treated dialysis tubing of 6-8 kDa cutoff size12. 
The active fractions, thus obtained, were collected and 
pooled for assessment of inhibitory activity14. The 
bioactivity of bacteriocin was analyzed at each point of 
purification by agar well diffusion assay (AWDA), in terms of 
AU/mL. After partial purification, protein concentration was 
measured15. 
FT-IR Analysis 
Determining the possible functional groups by FT-IR 
analysis was performed using Perkin Elmer to detect the 
characteristic peaks and their functional groups. The 
vibration pattern that appears in the infrared spectra 
provides information about the chemical functional group of 
the sample. 100 AU/mL-1 bacteriocin prepared and 10 × 0.6 
OD indicator strain were mixed and incubated at 37 °C for 
1h, 2h, and 3h. The control was used as without bacteriocin 
culture. A fraction of the sample was encased directly in the 
sample holder and spectra were scanned from 3442 to 682 
cm−1. 
Biofilm Formation Assay 
Methicillin-resistant Staphylococcus aureus was grown on 
Luria broth (LB; Himedia) at 37 °C for 18 h. 200 µL of 
bacterial cell suspension (about 106 CFU/mL) in Luria broth 
(LB) were inoculated in triplicates to wells of a tissue culture 
polystyrene 96-well plate. Biofilms were developed for 48 h 
at 37 °C. Subsequently, the medium was removed and the 
biofilms were washed twice with 250 µL of sterile 
phosphate-buffered saline (PBS, pH 7.2). Biofilms were fixed 
with 200 µL of methanol per well for 15 min and stained 
with 200 µL of 1% crystal violet per well (Sigma-Aldrich, 
Steinheim, Germany). After that, the plates were rinsed with 
distilled water and air-dried. Crystal violet was solved in 
96% ethanol to measure absorbance at 492 nm in a 
microplate reader (Bio-Rad, USA). Each assay was 
performed three times and the results were averaged. 
Values of absorbance <0.2 were considered to be weak 
producers, 0.2–0.4 were medium producers, and values >0.4 
were considered strong producers16. 
RESULTS 
Partial purification of bacteriocin from a soil isolate 
Pseudomonas aeruginosa TA6 
The crude bacteriocin preparation obtained from the cell-
free supernatant of P. aeruginosa TA6 after ammonium 
sulfate saturated precipitation (70%) was subjected to 
purification. The ultrafiltration of the crude bacteriocin was 
achieved by using dialysis tubing of cut off size 6-8 kDa. The 
bacteriocin activity was carried against Methicillin-resistant 
Staphylococcus aureus (MRSA) by agar well diffusion assay. 
The maximum antagonistic activity was observed to be 400 
AU/mL in the resolved partial purified bacteriocin. (Fig 1) 
 
 
Fig 1. Partially purified bacteriocin against MRSA. 
  
Fourier Transmission-Infra Red Analysis (FT-IR) 
The FT-IR spectral analysis of the extracellular extract of P. 
aeruginosa TA6 strain revealed that the spectral range of 
obtained functional group ranged was between 400 and 
4000 cm-1 from the results, it was observed that the peak 
signal recorded for 682.59,1046.13, 1103.95, 1165.28, 
1638.22, 2078.63, 2931.77 and 3442.15. The peak observed 
at 682.59, was due to the alkyl group (C–Cl). The vibration 
stretch recorded at 1046.13 aromatic groups (C-Br), 1103.95 
aromatic group (C-F), 1165.28 aromatic group (C-F). The 
sharp peak at 1638.22 cm-1 was due to the presence of N, N- 
disubstituted Amides. The small vibration stretch recorded 
at 2078.63 cm-1 represents the possible presence of 
thiocyanate (–N=C=S). Finally broadband at 3442.15 cm-1 
showed the presence of amide group (–CONH–) (Fig.2)
. 
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Fig 2. Bacteriocin functional group identified by FT-IR analysis. 
 
Biofilm inhibition by bacteriocin.  
When different concentrations of bacteriocin were 
incubated with Methicillin-resistant S. aureus for 4 h at 37 °C 
for adherence to the wells of microtiter plates, it inhibited 
biofilm attachment in a concentration-dependent manner. 
About 0.05% and 0.02% attachment of biofilm was observed 
in the presence of 1X MIC (10 μg/mL) and 2X MIC (20 
μg/mL) respectively.  Bacteriocin showed significant 
inhibitory activity against Methicillin-resistant S. aureus 
biofilm formation at 48 h, about its concentration.  For the 
non-treated controls, a biofilm formed consisted of nearly 
uniform, a thick layer of cells. While the biofilm treated with 
bacteriocin 10 μg/mL and 20 μg/mL was much less dense, 
and individually formed colonies could be seen (Fig. 3).
 
 
Fig 3. Biofilms treated with bacteriocin assessed by microscopy: A. non-treated control; B. Treated with bacteriocin 1X 
MIC (10 μg/mL); C. Treated with bacteriocin 2X MIC (20 μg/mL). 
DISCUSSION 
The growth of biofilms is a significant problem within the 
healthcare and food industries. Control of biofilms formed 
by microbial pathogens is an important subject for medical 
researchers since the development of biofilms on foreign-
body surfaces often causes biofilm-associated infections in 
patients with indwelling medical devices. The characteristic 
resistance offered by biofilm-associated communities of 
microorganisms leading to their persistent survival is an 
important challenge to address. Though, many antibiotics 
are effective against biofilms17. Furthermore, while it is 
suggested that bacteriocins may inhibit the development of 
biofilms18, their effect upon microbial cells in a biofilm is not 
fully understood. Methicillin-resistant Staphylococcus aureus 
(MRSA) is an alarming threat of interest that is responsible 
for either community-acquired (CA-MRSA) or health-care- 
acquired (HA-MRSA) infections. Staphylococcus aureus is an 
opportunistic pathogen causing a broad range of nosocomial 
and community-acquired infections. Diseases caused by this 
bacterium can range from skin infections to foodborne 
illnesses and severe infections such as endocarditis, 
osteomyelitis, and sepsis19. The continuous use of antibiotics 
has resulted in multiresistant bacterial strains all over the 
world20. Consequently, there is an urgent need to search for 
alternatives to synthetic antibiotics. 
Bacteriocins are the peptides and protein antibiotics which 
are produced by several species and have antimicrobial 
properties usually against other closely related species21. 
There are some reports available on bacteriocin-producing 
P. auroginosa isolated from soil samples but limited studies 
describe soil isolates8, 9. Bacteriocins of P. aeruginosa 
present an example of such excellence as >90% of its strains 
produce bacteriocins called Pyocins10, 22, 23. In this study, the 
effects of bacteriocin from P. aeruginosa TA6 against 
Methicillin-resistant staphylococcus aureus (MRSA). Among 
the bacteriocins, showed the highest bactericidal activities 
Thangarasu et al                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):438-441  
ISSN: 2250-1177                                                                                  [441]                                                                                 CODEN (USA): JDDTAO 
against biofilm cells. The partially purified bacteriocin has 
shown the highest activity (400AU/mL) against MRSA. The 
FT-IR spectrum of P. aeruginosa TA6 bacteriocin treated 
with MRSA. The strain was revealed that functional range at 
300 and 4000 cm-1. In bacteriocin treated cells shift in 
absorbance in low frequency at 682.59, 1046.13, 1103.95, 
1165.28, 1638.22, 2078.63, 2931.77 and 3442.15 cm-1. FT-IR 
spectroscopy has been applied as a reliable method to study 
the putative mode of action of cell lytic bacteriocins from P. 
aeruginosa on S. aureus. However, our result was 
contradicted the earlier report24. The fall in the emergence 
of new antimicrobials in the market during the past two 
decades is worrying, particularly given the rise in bacterial 
resistance against many of the currently used antibiotics. In 
addition to antimicrobial activities, bacteriocins serve as an 
anti-resistance compound to classic antibiotics as they can 
interact with bacterial membranes, create ion-permeable 
channels leading to increased cytoplasmic membrane 
permeability and hence, bacterial cell death25. When applied 
to preformed MRSA biofilms, bacteriocin was able to 
significantly reduce biofilm cell viability even at lower 
concentrations at 24-h incubation. These results suggest that 
bacteriocin is controlling for the growth of MRSA biofilm. 
Our results suggest that bacteriocins that form stable pores 
on biofilm cells are highly potent for the treatment of MRSA 
biofilm infections. 
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